Blue Rock Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Hold
356
0.24% 59
2026
Q1
$327K Hold
356
0.21% 71
2025
Q4
$383K Hold
356
0.24% 66
2025
Q3
$272K Buy
356
+56
+19% +$41.7K 0.17% 89
2025
Q2
$234K Hold
300
0.16% 89
2025
Q1
$248K Hold
300
0.21% 84
2024
Q4
$232K Buy
+300
New +$248K 0.24% 64

Other funds holding LLY

Blue Rock Wealth Management's LLY Position: Q2 2026 in Review

Blue Rock Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 356 shares worth $427K. The position accounts for 0.24% of the portfolio, ranked #59.

Blue Rock Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blue Rock Wealth Management held 356 shares of Eli Lilly worth $427K as of Q2 2026.
  • Blue Rock Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.24% of Blue Rock Wealth Management's portfolio in Q2 2026, its #59 holding.
  • Blue Rock Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blue Rock Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.